Visualize a new path forward
Empowering the immune system to recognize and eliminate tumors has tremendous potential to change the way cancer is treated and eventually cured. At Fluidigm, we enable comprehensive cellular profiling of the immune system and the tumor microenvironment with proven mass cytometry and microfluidics technologies.
Whether you seek to target new biomarkers and pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you identify new insights to reach your next research breakthrough.
Join us for a Dinner Seminar
Comprehensive Characterization of the Tumor Microenvironment with Imaging Mass Cytometry
Please join us for an evening of cocktails, dinner and presentations by leading researchers who are using Imaging Mass Cytometry™ to gain a comprehensive view of complex cellular phenotypes and their relationships in the context of the tumor microenvironment.
When: | Thursday, November 9, 2017
|
|
6:00‒7:00 pm Cocktails
7:00–10:00 pm Dinner and presentations |
Where: | The Sunset Room
137 National Plaza #200 National Harbor, Maryland |
Presenters
![]() |
Analysis of tissue ecosystems in health and disease by Imaging Mass Cytometry
Bernd Bodenmiller, PhD—University of Zurich |
![]() |
Understanding the immune composition of human lung cancer using Imaging Mass Cytometry
Kurt Schalper, MD, PhD—Yale University |
See Product Presentations
Visit Fluidigm at Booth 325 and hear about the Hyperion™ Imaging System, an exciting new product that is transforming tumor imaging.
Exhibition Dates & Hours
Friday, November 10: 12:30–7:45 pm
Saturday, November 11: 12:30–8:00 pm
Hyperion Imaging SystemComprehensively interrogate complex cellular phenotypes and their interrelationships in the context of the tumor microenvironment with Imaging Mass Cytometry. |
![]() |
Helios™, a CyTOF® systemDeeply profile immune and tumor cell populations for phenotype and function, all in a single tube. |
![]() |
Biomark HDReveal the molecular signatures of tumor immune response using the Advanta™ Immuno-Oncology Gene Expression Assay on the Biomark™ HD. |
![]() |
Visit Posters and Presentations Featuring Fluidigm Technology
Presentations: Thursday, November 9
Time |
Title |
Presenter, Institution |
Location |
10:35‒11:00 am | Myeloid cells in lung tumors using CyTOF® | Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai |
Workshop on Single Cell Techniques/ Session II, Tumor Immune Microenvironment |
11:00‒11:25 am | Computational methods for analyzing single cells in the tumor microenvironment | Dana Pe’er, PhD
Sloan Kettering Cancer Center |
|
Posters: Friday, November 10 and Saturday, November 11
Poster |
Title |
Presenter, Institution |
Location |
P80 | Testing systems immune monitoring by mass cytometry for clinical research | Caroline Roe, BS
Vanderbilt University |
Biomarkers and Immune Monitoring |
P173 | Mass cytometry based immunophenotyping of tumor-reactive T cells in human cancer reveals subpopulations with coordinate inhibitory molecule expression | Monika Aleksandra Eiva, BS
University of Pennsylvania |
Cellular Therapy Approaches |
P379 | Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade | Spencer Wei, PhD
The University of Texas MD Anderson Cancer Center |
Mechanisms of Efficacy or Toxicity |
P489 | Studying the cellular heterogeneity and spatial arrangement of immune cells in FFPE sections of Hodgkin Lymphoma and normal lymph node using a highly multiplexed Imaging Mass Cytometry | Mohan Singh, PhD
University of Southern California |
Tumor Microenvironment (Mechanisms and Therapies) |
Social Media
Can't make it to all of the sessions? Follow @fluidigm with #SITC2017 and like us on Facebook for scientific and event updates.
For Research Use Only. Not for use in diagnostic procedures.